Home › Companies › AGILON HEALTH INC. › 2024-2025
Compiled from SEC Form N-PX filings and AGILON HEALTH INC.’s Form 8-K, filed 2025-05-30 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore AGILON HEALTH INC. in the interactive database Compare manager voting policies
These tallies are AGILON HEALTH INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-30 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Silvana Battaglia | 367,732,187 | 2,575,657 | 73,996 | -- | 19,577,901 | Majority: yes |
| Elect Director: Sharad Mansukani, M.D. | 316,017,915 | 54,325,054 | 38,871 | -- | 19,577,901 | Majority: yes |
| Proposal 2: Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. | 385,547,549 | 4,346,548 | 65,644 | -- | -- | Majority: yes |
| Proposal 3: Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers. | 286,771,841 | 83,515,983 | 94,016 | -- | 19,577,901 | Majority: yes |
Source: AGILON HEALTH INC., Form 8-K, filed with the SEC on 2025-05-30 — read the filing on EDGAR.
Each item below shows how the 176 asset managers that disclosed a AGILON HEALTH INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of AGILON HEALTH INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 8 wordings of this item as funds reported it.
77% Majority: yes · of votes cast
AGILON HEALTH INC.’s own tally for this item (“Proposal 3: Non-Binding Vote on Executive Compensation The stockholders approved, on an advisory, non-binding basis, the compensation paid to the Company's named executive officers.”): 286,771,841 for, 83,515,983 against, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 413,023,000 outstanding shares: 69% for, 20% against (90% of the company cast a for/against vote).
The 174 asset managers below cast 70% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 52 | 140,518,735 | 0 | 0 | Against |
| Clayton, Dubilier & Rice, LLC | 100,000,000 | 0 | 0 | 0 | For |
| Morgan Stanley | 67,961,850 | 0 | 0 | 0 | For |
| Fidelity | 48,340,515 | 0 | 0 | 0 | For |
| Vanguard | 36,611,011 | 0 | 0 | 0 | For |
| BlackRock | 21,533,623 | 2,942 | 0 | 0 | For |
| Wellington | 13,509,685 | 0 | 0 | 0 | For |
| Charles Schwab | 9,858,068 | 0 | 0 | 0 | For |
| Brighthouse | 7,347,128 | 0 | 31,549 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 6,987,748 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 6,950,000 | 0 | 0 | 0 | For |
| State Street | 6,682,961 | 0 | 0 | 0 | For |
| Rubicon Founders LLC | 0 | 0 | 6,292,396 | 0 | Abstain |
| NEW ECONOMY FUND | 0 | 5,866,895 | 0 | 0 | Against |
| Nuveen | 5,833,373 | 0 | 0 | 0 | For |
| TIAA | 5,791,820 | 0 | 0 | 0 | For |
| Equitable | 3,996,862 | 0 | 0 | 0 | For |
| Northern Trust | 2,587,947 | 0 | 0 | 0 | For |
| Invesco | 0 | 1,616,221 | 0 | 0 | Against |
| Amundi | 0 | 1,484,709 | 0 | 0 | Against |
| JPMorgan | 1,059,524 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 976,727 | 0 | 0 | 0 | For |
| DE Shaw | 846,689 | 0 | 0 | 0 | For |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| ALGERT GLOBAL LLC | 0 | 798,011 | 0 | 0 | Against |
Showing the 25 largest of 174 asset managers. See all 174 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
AGILON HEALTH INC.’s own tally for this item (“Proposal 2: Ratification of Independent Registered Public Accounting Firm The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ”): 385,547,549 for, 4,346,548 against, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 413,023,000 outstanding shares: 93% for, 1% against (94% of the company cast a for/against vote).
The 53 asset managers below cast 100% of the shares they voted on this item FOR (194,904,591 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 65,184,327 | 0 | 0 | 0 | For |
| Vanguard | 35,725,257 | 0 | 0 | 0 | For |
| Fidelity | 27,760,191 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 11,091,520 | 0 | 0 | 0 | For |
| Brighthouse | 7,347,128 | 0 | 31,549 | 0 | For |
| NEW ECONOMY FUND | 5,866,895 | 0 | 0 | 0 | For |
| TIAA | 5,791,820 | 0 | 0 | 0 | For |
| Charles Schwab | 4,929,028 | 0 | 0 | 0 | For |
| Equitable | 3,996,862 | 0 | 0 | 0 | For |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| Invesco | 715,488 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 672,080 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 518,720 | 0 | 0 | 0 | For |
| Global X | 409,144 | 0 | 0 | 0 | For |
| Goldman Sachs | 399,439 | 0 | 0 | 0 | For |
| State Street | 382,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 301,533 | 0 | 0 | 0 | For |
| DWS | 245,556 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 228,279 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 184,911 | 0 | 0 | 0 | For |
| Northern Trust | 157,172 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 151,134 | 0 | 0 | 0 | For |
| American Century | 144,998 | 0 | 0 | 0 | For |
| T. Rowe Price | 137,910 | 0 | 0 | 0 | For |
Showing the 25 largest of 53 asset managers. See all 53 in the interactive database.
Combines 3 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
AGILON HEALTH INC.’s own tally for this item (“Elect Director: Sharad Mansukani, M.D.”): 316,017,915 for, 54,325,054 against, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 413,023,000 outstanding shares: 77% for, 13% against (90% of the company cast a for/against vote).
The 52 asset managers below cast 88% of the shares they voted on this item FOR (172,168,946 for, 22,625,125 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 65,184,327 | 0 | 0 | 0 | For |
| Vanguard | 35,662,457 | 62,800 | 0 | 0 | For |
| Fidelity | 27,540,308 | 219,883 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 0 | 11,091,520 | 0 | 0 | Against |
| Brighthouse | 7,214,827 | 132,301 | 31,549 | 0 | For |
| NEW ECONOMY FUND | 5,866,895 | 0 | 0 | 0 | For |
| TIAA | 0 | 5,791,820 | 0 | 0 | Against |
| Charles Schwab | 4,929,028 | 0 | 0 | 0 | For |
| Equitable | 3,177,976 | 818,886 | 0 | 0 | For |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| Invesco | 0 | 715,488 | 0 | 0 | Against |
| Exchange Place Advisors Trust | 0 | 672,080 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 518,720 | 0 | 0 | Against |
| Global X | 0 | 409,144 | 0 | 0 | Against |
| Goldman Sachs | 0 | 399,439 | 0 | 0 | Against |
| State Street | 381,535 | 1,048 | 0 | 0 | For |
| Lincoln Financial | 285,005 | 16,528 | 0 | 0 | For |
| DWS | 0 | 245,556 | 0 | 0 | Against |
| TIFF INVESTMENT PROGRAM | 0 | 228,279 | 0 | 0 | Against |
| NORTHERN LIGHTS FUND TRUST III | 184,911 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 157,172 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 151,134 | 0 | 0 | Against |
| American Century | 0 | 144,998 | 0 | 0 | Against |
| T. Rowe Price | 137,910 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. See all 52 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
AGILON HEALTH INC.’s own tally for this item (“Elect Director: Silvana Battaglia”): 367,732,187 for, 2,575,657 against, per its Form 8-K filed 2025-05-30 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 413,023,000 outstanding shares: 89% for, 0.7% against (90% of the company cast a for/against vote).
The 47 asset managers below cast 99.8% of the shares they voted on this item FOR (180,502,548 for, 303,747 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Capital Group | 65,184,327 | 0 | 0 | 0 | For |
| Vanguard | 29,718,275 | 0 | 0 | 0 | For |
| Fidelity | 26,889,225 | 0 | 0 | 0 | For |
| Morgan Stanley | 20,314,070 | 0 | 0 | 0 | For |
| BlackRock | 11,091,520 | 0 | 0 | 0 | For |
| Brighthouse | 6,495,079 | 0 | 0 | 0 | For |
| NEW ECONOMY FUND | 5,866,895 | 0 | 0 | 0 | For |
| TIAA | 5,791,820 | 0 | 0 | 0 | For |
| Equitable | 3,996,862 | 0 | 0 | 0 | For |
| Invesco | 715,488 | 0 | 0 | 0 | For |
| Exchange Place Advisors Trust | 672,080 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 518,720 | 0 | 0 | 0 | For |
| Goldman Sachs | 399,439 | 0 | 0 | 0 | For |
| State Street | 382,583 | 0 | 0 | 0 | For |
| Lincoln Financial | 285,005 | 16,528 | 0 | 0 | For |
| DWS | 245,556 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 228,279 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 0 | 184,911 | 0 | 0 | Against |
| Northern Trust | 157,172 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 151,134 | 0 | 0 | 0 | For |
| American Century | 144,998 | 0 | 0 | 0 | For |
| T. Rowe Price | 137,910 | 0 | 0 | 0 | For |
| Voya | 133,598 | 0 | 0 | 0 | For |
| John Hancock | 111,897 | 0 | 0 | 0 | For |
| JPMorgan | 109,594 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
100% fund support · no official result
The 10 asset managers below cast 100% of the shares they voted on this item FOR (13,987,776 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,006,982 | 0 | 0 | 0 | For |
| Charles Schwab | 4,929,028 | 0 | 0 | 0 | For |
| Brighthouse | 852,049 | 0 | 31,549 | 0 | For |
| Fidelity | 870,966 | 0 | 0 | 0 | For |
| Hartford | 800,962 | 0 | 0 | 0 | For |
| Global X | 409,144 | 0 | 0 | 0 | For |
| Forethought Variable Insurance Trust | 59,314 | 0 | 0 | 0 | For |
| SEI | 42,900 | 0 | 0 | 0 | For |
| Victory Capital | 8,730 | 0 | 0 | 0 | For |
| Nationwide | 7,701 | 0 | 0 | 0 | For |
Ranked by the number of AGILON HEALTH INC. shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 413,023,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Capital Group | 34.02% |
| 2 | Clayton, Dubilier & Rice, LLC | 24.21% |
| 3 | Morgan Stanley | 16.45% |
| 4 | Fidelity | 11.70% |
| 5 | Vanguard | 8.86% |
| 6 | BlackRock | 5.21% |
| 7 | Wellington | 3.27% |
| 8 | Charles Schwab | 2.39% |
| 9 | Brighthouse | 1.79% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 1.69% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Morgan Stanley | 12.60% | 13F |
| North Peak Capital Management, LLC | 9.54% | 13G |
| Vanguard Group | 7.33% | 13F |
| BlackRock | 5.99% | 13F |
| FMR (Fidelity) | 4.62% | 13F |
| Wellington Management | 3.63% | 13F |
| Capital World Investors | 2.63% | 13G |
| Capital International Investors | 2.40% | 13G |
| Citadel Advisors | 2.03% | 13F |
| State Street | 1.79% | 13F |
Percentages above are of 413,023,000 shares outstanding, as reported by AGILON HEALTH INC. on its Form 10-Q dated 2025-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from AGILON HEALTH INC.’s 10-Q dated 2025-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At AGILON HEALTH INC.'s shareholder meeting held 2025-05-28, in the 2024-2025 proxy season, 176 asset managers reported how they voted in their SEC Form N-PX filings, covering 928 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — TO APPROVE, BY ADVISORY VOTE, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS. — FOR was 77% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: AGILON HEALTH INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-30.
AGILON HEALTH INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.